Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Outcomes of Pre-Early Treatment for Retinopathy of Prematurity (Pre-ETROP)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Titawattanakul,Yothin; Kulvichit,Kittisak; Varadisai,Adisai; Mavichak,Apivat
  • نوع التسجيلة:
    Electronic Resource
  • الدخول الالكتروني :
    https://www.dovepress.com/outcomes-of-pre-early-treatment-for-retinopathy-of-prematurity-pre-etr-peer-reviewed-fulltext-article-OPTH
    info:eu-repo/semantics/altIdentifier/doi/10.2147/OPTH.S268997
  • معلومة اضافية
    • Publisher Information:
      Dove Press 2020-10-16
    • نبذة مختصرة :
      Yothin Titawattanakul, Kittisak Kulvichit, Adisai Varadisai, Apivat Mavichak Vitreo-retina Research Unit, Department of Ophthalmology, Faculty of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, ThailandCorrespondence: Kittisak KulvichitDepartment of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, ThailandTel +66 2 2564000Email kulvichit@gmail.comIntroduction: The earlier treat stage 3 ROP is more likely to achieve better outcomes.Primary Purpose: To study the unfavorable outcomes and regression after pre-early treatment for ROP.Secondary Purpose: To evaluate the progression and recurrence of ROP requiring retreatment after pre-early treatment for ROP.Patients and Methods: The data were retrieved retrospectively from the medical records of all infants who were screened and treated for ROP from January 2009 to January 2014 at a tertiary care facility. The outcomes measured the following: 1. unfavorable outcomes; 2. regression of ROP; 3. progression of ROP and 4. recurrence of ROP requiring retreatment. We treated all stage 3 ROP in any zone, with or without plus. The study also compared the outcomes between the pre-ETROP and the ETROP subgroups.Results: There were 91 eyes with stage 3 ROP. Of the total of 91 eyes, there were 63 eyes with the pre-ETROP group and 28 eyes of the ETROP group. The unfavorable outcomes after treatment occur 6 eyes from 28 eyes (21.43%) in the ETROP group but no unfavorable outcomes in the pre-ETROP group (P=0.001). The pre-ETROP group who were treated with laser LIO alone had 100% regression, while the ETROP group who were treated with LIO (26 eyes) had 88.46% regression. There were 2 eyes of this group who were treated with a combination of LIO and IVT Bevacizumab. Both of them did not have regression. The recurrence of ROP requiring retreatment occurred in 2 eyes (7.14%) of the ETROP group, but no recurrence in the pre-ETROP group (P=0.092). The progression after treatment occurred
    • الموضوع:
      Clinical Ophthalmology; Original Research; info:eu-repo/semantics/article
    • Availability:
      Open access content. Open access content
      info:eu-repo/semantics/openAccess
    • Note:
      text/html
      English
    • Other Numbers:
      NZDMP oai:dovepress.com/58219
      1224221400
    • Contributing Source:
      DOVE MEDL PRESS LTD
      From OAIster®, provided by the OCLC Cooperative.
    • الرقم المعرف:
      edsoai.on1224221400
HoldingsOnline